TRIM71 and liver cancer: Treatment with ATRA significantly decreased TRIM71 expression, leading to the inhibition of colony formation ability in liver cancer cells with high TRIM71 expression but with little effect on TRIM71-negative liver cancer cells, indicating that clinical ATRA treatment should consider the oncofetal characteristics and high TRIM71 expression of liver cancer patients.